These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28179354)

  • 1. Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Liberale G; Lecocq C; Garcia C; Muylle K; Covas A; Deleporte A; Hendlisz A; Bouazza F; El Nakadi I; Flamen P
    Anticancer Res; 2017 Feb; 37(2):929-934. PubMed ID: 28179354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
    Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
    Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
    Audollent R; Eveno C; Dohan A; Sarda L; Jouvin I; Soyer P; Pocard M
    J Visc Surg; 2015 Nov; 152(5):285-91. PubMed ID: 26115889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
    Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
    Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
    Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
    Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of PET/CT in peritoneal carcinomatosis from colorectal cancer.
    Bamba Y; Itabashi M; Kameoka S
    Hepatogastroenterology; 2012; 59(117):1408-11. PubMed ID: 22094993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery.
    Pasqual EM; Bertozzi S; Bacchetti S; Londero AP; Basso SM; Santeufemia DA; Lo Re G; Lumachi F
    Anticancer Res; 2014 May; 34(5):2363-8. PubMed ID: 24778044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer.
    Tanaka T; Kawai Y; Kanai M; Taki Y; Nakamoto Y; Takabayashi A
    Am J Surg; 2002 Nov; 184(5):433-6. PubMed ID: 12433608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Sommariva A; Evangelista L; Pintacuda G; Cervino AR; Ramondo G; Rossi CR
    Abdom Radiol (NY); 2018 May; 43(5):1094-1100. PubMed ID: 28770289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT.
    Kim HW; Won KS; Zeon SK; Ahn BC; Gayed IW
    Clin Nucl Med; 2013 Feb; 38(2):93-7. PubMed ID: 23334121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can [
    Elekonawo FMK; Starremans B; Laurens ST; Bremers AJA; de Wilt JHW; Heijmen L; de Geus-Oei LF
    Abdom Radiol (NY); 2020 Feb; 45(2):301-306. PubMed ID: 31642963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
    Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
    J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy.
    Berthelot C; Morel O; Girault S; Verrièle V; Poirier AL; Moroch J; Boucher Y; Le Jeune JJ; Lorimier G
    Nucl Med Commun; 2011 Jan; 32(1):23-9. PubMed ID: 21042225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.
    Klumpp BD; Schwenzer N; Aschoff P; Miller S; Kramer U; Claussen CD; Bruecher B; Koenigsrainer A; Pfannenberg C
    Abdom Imaging; 2013 Feb; 38(1):64-71. PubMed ID: 22476333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT.
    Dromain C; Leboulleux S; Auperin A; Goere D; Malka D; Lumbroso J; Schumberger M; Sigal R; Elias D
    Abdom Imaging; 2008; 33(1):87-93. PubMed ID: 17632751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of dual-time point imaging after carbonated water for the fluorodeoxyglucose positron emission imaging of peritoneal carcinomatosis in colon cancer.
    Filippi L; D'Arienzo M; Scopinaro F; Salvatori R; Bagni O
    Cancer Biother Radiopharm; 2013 Feb; 28(1):29-33. PubMed ID: 23134220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.